nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—CYP2D6—Parkinson's disease	0.547	1	CbGaD
Celecoxib—PDPK1—embryo—Parkinson's disease	0.00618	0.0454	CbGeAlD
Celecoxib—PDPK1—forebrain—Parkinson's disease	0.00547	0.0401	CbGeAlD
Celecoxib—MAPK14—hindbrain—Parkinson's disease	0.00529	0.0388	CbGeAlD
Celecoxib—PDPK1—medulla oblongata—Parkinson's disease	0.00395	0.029	CbGeAlD
Celecoxib—PDPK1—midbrain—Parkinson's disease	0.00361	0.0265	CbGeAlD
Celecoxib—PDPK1—spinal cord—Parkinson's disease	0.00352	0.0259	CbGeAlD
Celecoxib—Etoricoxib—CYP2E1—Parkinson's disease	0.00351	0.464	CrCbGaD
Celecoxib—CA4—nerve—Parkinson's disease	0.00332	0.0243	CbGeAlD
Celecoxib—MAPK14—embryo—Parkinson's disease	0.00331	0.0243	CbGeAlD
Celecoxib—PDPK1—head—Parkinson's disease	0.00313	0.023	CbGeAlD
Celecoxib—MAPK14—brainstem—Parkinson's disease	0.00303	0.0222	CbGeAlD
Celecoxib—PDPK1—nervous system—Parkinson's disease	0.00297	0.0218	CbGeAlD
Celecoxib—MAPK14—forebrain—Parkinson's disease	0.00292	0.0215	CbGeAlD
Celecoxib—PDPK1—central nervous system—Parkinson's disease	0.00286	0.021	CbGeAlD
Celecoxib—PDPK1—cerebellum—Parkinson's disease	0.00279	0.0205	CbGeAlD
Celecoxib—Etoricoxib—CYP2D6—Parkinson's disease	0.00258	0.34	CrCbGaD
Celecoxib—CA4—hindbrain—Parkinson's disease	0.00248	0.0182	CbGeAlD
Celecoxib—MAPK14—cardiovascular system—Parkinson's disease	0.00247	0.0181	CbGeAlD
Celecoxib—PDPK1—brain—Parkinson's disease	0.00227	0.0167	CbGeAlD
Celecoxib—CA12—forebrain—Parkinson's disease	0.00222	0.0163	CbGeAlD
Celecoxib—CA2—hindbrain—Parkinson's disease	0.00206	0.0151	CbGeAlD
Celecoxib—CA14—medulla oblongata—Parkinson's disease	0.00206	0.0151	CbGeAlD
Celecoxib—CA6—head—Parkinson's disease	0.00189	0.0139	CbGeAlD
Celecoxib—MAPK14—spinal cord—Parkinson's disease	0.00188	0.0138	CbGeAlD
Celecoxib—CA14—midbrain—Parkinson's disease	0.00188	0.0138	CbGeAlD
Celecoxib—CA14—spinal cord—Parkinson's disease	0.00183	0.0135	CbGeAlD
Celecoxib—CA5B—cardiovascular system—Parkinson's disease	0.00168	0.0124	CbGeAlD
Celecoxib—MAPK14—head—Parkinson's disease	0.00167	0.0123	CbGeAlD
Celecoxib—MAPK14—nervous system—Parkinson's disease	0.00159	0.0117	CbGeAlD
Celecoxib—CA9—cerebellum—Parkinson's disease	0.00153	0.0112	CbGeAlD
Celecoxib—MAPK14—central nervous system—Parkinson's disease	0.00153	0.0112	CbGeAlD
Celecoxib—ABCC4—forebrain—Parkinson's disease	0.00149	0.011	CbGeAlD
Celecoxib—MAPK14—cerebellum—Parkinson's disease	0.00149	0.011	CbGeAlD
Celecoxib—Sulfaphenazole—CYP2D6—Parkinson's disease	0.00149	0.196	CrCbGaD
Celecoxib—CA14—cerebellum—Parkinson's disease	0.00145	0.0107	CbGeAlD
Celecoxib—CA4—brainstem—Parkinson's disease	0.00142	0.0104	CbGeAlD
Celecoxib—CA4—forebrain—Parkinson's disease	0.00137	0.0101	CbGeAlD
Celecoxib—CYP2D6—hindbrain—Parkinson's disease	0.00131	0.0096	CbGeAlD
Celecoxib—CA2—embryo—Parkinson's disease	0.00129	0.00945	CbGeAlD
Celecoxib—CA12—head—Parkinson's disease	0.00127	0.00932	CbGeAlD
Celecoxib—MAPK14—brain—Parkinson's disease	0.00121	0.00891	CbGeAlD
Celecoxib—CA12—nervous system—Parkinson's disease	0.0012	0.00884	CbGeAlD
Celecoxib—CA14—brain—Parkinson's disease	0.00118	0.00866	CbGeAlD
Celecoxib—CA2—brainstem—Parkinson's disease	0.00118	0.00866	CbGeAlD
Celecoxib—CA4—cardiovascular system—Parkinson's disease	0.00116	0.00853	CbGeAlD
Celecoxib—CA12—central nervous system—Parkinson's disease	0.00116	0.00851	CbGeAlD
Celecoxib—CA5B—head—Parkinson's disease	0.00114	0.00836	CbGeAlD
Celecoxib—CA2—forebrain—Parkinson's disease	0.00114	0.00836	CbGeAlD
Celecoxib—ORM1—spinal cord—Parkinson's disease	0.00113	0.00832	CbGeAlD
Celecoxib—CA5B—nervous system—Parkinson's disease	0.00108	0.00793	CbGeAlD
Celecoxib—CA5B—central nervous system—Parkinson's disease	0.00104	0.00763	CbGeAlD
Celecoxib—CA4—medulla oblongata—Parkinson's disease	0.000992	0.00728	CbGeAlD
Celecoxib—CA2—cardiovascular system—Parkinson's disease	0.000963	0.00707	CbGeAlD
Celecoxib—ORM1—nervous system—Parkinson's disease	0.000956	0.00701	CbGeAlD
Celecoxib—PTGS2—embryo—Parkinson's disease	0.000951	0.00698	CbGeAlD
Celecoxib—CA12—brain—Parkinson's disease	0.00092	0.00676	CbGeAlD
Celecoxib—ORM1—central nervous system—Parkinson's disease	0.00092	0.00675	CbGeAlD
Celecoxib—CA4—midbrain—Parkinson's disease	0.000907	0.00666	CbGeAlD
Celecoxib—CA4—spinal cord—Parkinson's disease	0.000885	0.0065	CbGeAlD
Celecoxib—ABCC4—head—Parkinson's disease	0.000856	0.00628	CbGeAlD
Celecoxib—PTGS2—forebrain—Parkinson's disease	0.000841	0.00617	CbGeAlD
Celecoxib—CA5B—brain—Parkinson's disease	0.000826	0.00606	CbGeAlD
Celecoxib—CA2—medulla oblongata—Parkinson's disease	0.000823	0.00604	CbGeAlD
Celecoxib—CYP2C9—cardiovascular system—Parkinson's disease	0.000815	0.00598	CbGeAlD
Celecoxib—ABCC4—nervous system—Parkinson's disease	0.000811	0.00595	CbGeAlD
Celecoxib—CA4—head—Parkinson's disease	0.000786	0.00577	CbGeAlD
Celecoxib—ABCC4—central nervous system—Parkinson's disease	0.000781	0.00573	CbGeAlD
Celecoxib—CA2—midbrain—Parkinson's disease	0.000752	0.00552	CbGeAlD
Celecoxib—CYP2D6—brainstem—Parkinson's disease	0.000749	0.0055	CbGeAlD
Celecoxib—CA4—nervous system—Parkinson's disease	0.000746	0.00547	CbGeAlD
Celecoxib—CA2—spinal cord—Parkinson's disease	0.000734	0.00539	CbGeAlD
Celecoxib—CYP2D6—forebrain—Parkinson's disease	0.000723	0.00531	CbGeAlD
Celecoxib—CA4—central nervous system—Parkinson's disease	0.000718	0.00527	CbGeAlD
Celecoxib—PTGS2—cardiovascular system—Parkinson's disease	0.000711	0.00522	CbGeAlD
Celecoxib—CA4—cerebellum—Parkinson's disease	0.000702	0.00515	CbGeAlD
Celecoxib—CA2—head—Parkinson's disease	0.000652	0.00479	CbGeAlD
Celecoxib—ALB—brain—Parkinson's disease	0.00064	0.0047	CbGeAlD
Celecoxib—ABCC4—brain—Parkinson's disease	0.00062	0.00455	CbGeAlD
Celecoxib—CA2—nervous system—Parkinson's disease	0.000618	0.00454	CbGeAlD
Celecoxib—PTGS2—medulla oblongata—Parkinson's disease	0.000607	0.00446	CbGeAlD
Celecoxib—CA2—central nervous system—Parkinson's disease	0.000595	0.00437	CbGeAlD
Celecoxib—CA2—cerebellum—Parkinson's disease	0.000582	0.00427	CbGeAlD
Celecoxib—CA4—brain—Parkinson's disease	0.00057	0.00418	CbGeAlD
Celecoxib—PTGS2—midbrain—Parkinson's disease	0.000555	0.00408	CbGeAlD
Celecoxib—PTGS2—spinal cord—Parkinson's disease	0.000542	0.00398	CbGeAlD
Celecoxib—PTGS2—head—Parkinson's disease	0.000481	0.00353	CbGeAlD
Celecoxib—CA2—brain—Parkinson's disease	0.000473	0.00347	CbGeAlD
Celecoxib—PTGS2—nervous system—Parkinson's disease	0.000456	0.00335	CbGeAlD
Celecoxib—PTGS2—central nervous system—Parkinson's disease	0.000439	0.00323	CbGeAlD
Celecoxib—PTGS2—cerebellum—Parkinson's disease	0.00043	0.00315	CbGeAlD
Celecoxib—CYP2D6—head—Parkinson's disease	0.000414	0.00304	CbGeAlD
Celecoxib—CYP3A4—nervous system—Parkinson's disease	0.000399	0.00293	CbGeAlD
Celecoxib—CYP2D6—nervous system—Parkinson's disease	0.000393	0.00288	CbGeAlD
Celecoxib—CYP3A4—central nervous system—Parkinson's disease	0.000384	0.00282	CbGeAlD
Celecoxib—CYP2D6—central nervous system—Parkinson's disease	0.000378	0.00277	CbGeAlD
Celecoxib—CYP2D6—cerebellum—Parkinson's disease	0.000369	0.00271	CbGeAlD
Celecoxib—PTGS2—brain—Parkinson's disease	0.000349	0.00256	CbGeAlD
Celecoxib—CYP2D6—brain—Parkinson's disease	0.0003	0.0022	CbGeAlD
Celecoxib—ALB—Hemostasis—FGB—Parkinson's disease	4.76e-05	0.000154	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NDUFB11—Parkinson's disease	4.75e-05	0.000154	CbGpPWpGaD
Celecoxib—PDPK1—Disease—APOE—Parkinson's disease	4.7e-05	0.000152	CbGpPWpGaD
Celecoxib—CA2—Metabolism—GPX1—Parkinson's disease	4.69e-05	0.000152	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—MAPK8—Parkinson's disease	4.66e-05	0.000151	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	4.64e-05	0.00015	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—HSPA8—Parkinson's disease	4.55e-05	0.000147	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GCH1—Parkinson's disease	4.53e-05	0.000147	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—CTGF—Parkinson's disease	4.53e-05	0.000147	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PDYN—Parkinson's disease	4.53e-05	0.000147	CbGpPWpGaD
Celecoxib—CA4—Metabolism—MTHFR—Parkinson's disease	4.51e-05	0.000146	CbGpPWpGaD
Celecoxib—CA9—Metabolism—COMT—Parkinson's disease	4.51e-05	0.000146	CbGpPWpGaD
Celecoxib—CA12—Metabolism—INS—Parkinson's disease	4.5e-05	0.000146	CbGpPWpGaD
Celecoxib—CA9—Metabolism—GSTP1—Parkinson's disease	4.49e-05	0.000145	CbGpPWpGaD
Celecoxib—CA9—Metabolism—MAOA—Parkinson's disease	4.48e-05	0.000145	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	4.47e-05	0.000145	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—COMT—Parkinson's disease	4.44e-05	0.000144	CbGpPWpGaD
Celecoxib—CA9—Metabolism—HMOX1—Parkinson's disease	4.43e-05	0.000143	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	4.42e-05	0.000143	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	4.41e-05	0.000143	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MCCC1—Parkinson's disease	4.4e-05	0.000143	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ND3—Parkinson's disease	4.4e-05	0.000143	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—INS—Parkinson's disease	4.4e-05	0.000142	CbGpPWpGaD
Celecoxib—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	4.38e-05	0.000142	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ND3—Parkinson's disease	4.37e-05	0.000141	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MCCC1—Parkinson's disease	4.37e-05	0.000141	CbGpPWpGaD
Celecoxib—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	4.36e-05	0.000141	CbGpPWpGaD
Celecoxib—CA2—Metabolism—MTHFR—Parkinson's disease	4.32e-05	0.00014	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GFAP—Parkinson's disease	4.26e-05	0.000138	CbGpPWpGaD
Celecoxib—CA9—Metabolism—ABCB1—Parkinson's disease	4.25e-05	0.000138	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IGF2—Parkinson's disease	4.24e-05	0.000137	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GRM5—Parkinson's disease	4.21e-05	0.000136	CbGpPWpGaD
Celecoxib—CA4—Metabolism—APOE—Parkinson's disease	4.2e-05	0.000136	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—ADRBK1—Parkinson's disease	4.2e-05	0.000136	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—IL6—Parkinson's disease	4.2e-05	0.000136	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—HSPA1A—Parkinson's disease	4.15e-05	0.000134	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—TALDO1—Parkinson's disease	4.14e-05	0.000134	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—OMD—Parkinson's disease	4.14e-05	0.000134	CbGpPWpGaD
Celecoxib—CA9—Metabolism—GSTM1—Parkinson's disease	4.12e-05	0.000134	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	4.11e-05	0.000133	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—OMD—Parkinson's disease	4.1e-05	0.000133	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—TALDO1—Parkinson's disease	4.1e-05	0.000133	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IGF1R—Parkinson's disease	4.1e-05	0.000133	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	4.09e-05	0.000132	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	4.06e-05	0.000131	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—EDN1—Parkinson's disease	4.05e-05	0.000131	CbGpPWpGaD
Celecoxib—ALB—Metabolism—FBP1—Parkinson's disease	4.04e-05	0.000131	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GBA—Parkinson's disease	4.04e-05	0.000131	CbGpPWpGaD
Celecoxib—ALB—Metabolism—DBH—Parkinson's disease	4.04e-05	0.000131	CbGpPWpGaD
Celecoxib—CA2—Metabolism—APOE—Parkinson's disease	4.03e-05	0.00013	CbGpPWpGaD
Celecoxib—PDPK1—Disease—INS—Parkinson's disease	4.02e-05	0.00013	CbGpPWpGaD
Celecoxib—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	4e-05	0.00013	CbGpPWpGaD
Celecoxib—CA9—Metabolism—GPX1—Parkinson's disease	3.95e-05	0.000128	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—IL6—Parkinson's disease	3.95e-05	0.000128	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	3.92e-05	0.000127	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	3.89e-05	0.000126	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—IL6—Parkinson's disease	3.87e-05	0.000125	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—IL6—Parkinson's disease	3.86e-05	0.000125	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GCH1—Parkinson's disease	3.74e-05	0.000121	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NGF—Parkinson's disease	3.72e-05	0.000121	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GCH1—Parkinson's disease	3.71e-05	0.00012	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—FGF20—Parkinson's disease	3.69e-05	0.00012	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—DDC—Parkinson's disease	3.67e-05	0.000119	CbGpPWpGaD
Celecoxib—CA9—Metabolism—MTHFR—Parkinson's disease	3.65e-05	0.000118	CbGpPWpGaD
Celecoxib—PTGS2—Disease—RPL23A—Parkinson's disease	3.61e-05	0.000117	CbGpPWpGaD
Celecoxib—PTGS2—Disease—RPL14—Parkinson's disease	3.61e-05	0.000117	CbGpPWpGaD
Celecoxib—CA4—Metabolism—INS—Parkinson's disease	3.59e-05	0.000116	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ADORA2A—Parkinson's disease	3.58e-05	0.000116	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—HTR2A—Parkinson's disease	3.54e-05	0.000115	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—SOD1—Parkinson's disease	3.54e-05	0.000115	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.53e-05	0.000114	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GSTA4—Parkinson's disease	3.46e-05	0.000112	CbGpPWpGaD
Celecoxib—CA2—Metabolism—INS—Parkinson's disease	3.44e-05	0.000111	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—ABL1—Parkinson's disease	3.42e-05	0.000111	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.42e-05	0.000111	CbGpPWpGaD
Celecoxib—CA9—Metabolism—APOE—Parkinson's disease	3.39e-05	0.00011	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.39e-05	0.00011	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—ABL1—Parkinson's disease	3.37e-05	0.000109	CbGpPWpGaD
Celecoxib—PTGS2—Disease—FGF20—Parkinson's disease	3.37e-05	0.000109	CbGpPWpGaD
Celecoxib—PTGS2—Disease—RPS8—Parkinson's disease	3.37e-05	0.000109	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IGF2—Parkinson's disease	3.36e-05	0.000109	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	3.35e-05	0.000108	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—DBH—Parkinson's disease	3.34e-05	0.000108	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—FBP1—Parkinson's disease	3.34e-05	0.000108	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GBA—Parkinson's disease	3.34e-05	0.000108	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—DBH—Parkinson's disease	3.31e-05	0.000107	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—FBP1—Parkinson's disease	3.31e-05	0.000107	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GBA—Parkinson's disease	3.31e-05	0.000107	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—INSR—Parkinson's disease	3.31e-05	0.000107	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—APOE—Parkinson's disease	3.29e-05	0.000107	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—IL6—Parkinson's disease	3.27e-05	0.000106	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	3.25e-05	0.000105	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL1B—Parkinson's disease	3.25e-05	0.000105	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HGF—Parkinson's disease	3.22e-05	0.000104	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—HGF—Parkinson's disease	3.17e-05	0.000103	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—IL6—Parkinson's disease	3.17e-05	0.000103	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—FGB—Parkinson's disease	3.12e-05	0.000101	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PLA2G6—Parkinson's disease	3.12e-05	0.000101	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HTR1A—Parkinson's disease	3.11e-05	0.000101	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—MAOB—Parkinson's disease	3.09e-05	9.99e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TAC1—Parkinson's disease	3.06e-05	9.91e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—DRD1—Parkinson's disease	3e-05	9.72e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—MAPK8—Parkinson's disease	2.98e-05	9.64e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—IL6—Parkinson's disease	2.98e-05	9.63e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—DDC—Parkinson's disease	2.97e-05	9.6e-05	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.95e-05	9.54e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.94e-05	9.51e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—DRD3—Parkinson's disease	2.91e-05	9.41e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—INS—Parkinson's disease	2.9e-05	9.39e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ND3—Parkinson's disease	2.88e-05	9.32e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MCCC1—Parkinson's disease	2.88e-05	9.32e-05	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.83e-05	9.16e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—INS—Parkinson's disease	2.81e-05	9.11e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GSTA4—Parkinson's disease	2.8e-05	9.07e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.77e-05	8.96e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ADRBK1—Parkinson's disease	2.72e-05	8.79e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—TALDO1—Parkinson's disease	2.71e-05	8.76e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—OMD—Parkinson's disease	2.71e-05	8.76e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—MAPK8—Parkinson's disease	2.66e-05	8.61e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—DRD2—Parkinson's disease	2.63e-05	8.51e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HTR7—Parkinson's disease	2.63e-05	8.51e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	2.57e-05	8.31e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PLA2G6—Parkinson's disease	2.52e-05	8.17e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—MAOB—Parkinson's disease	2.5e-05	8.08e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ADRBK1—Parkinson's disease	2.48e-05	8.02e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HSPA1A—Parkinson's disease	2.46e-05	7.96e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—DDC—Parkinson's disease	2.45e-05	7.93e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GCH1—Parkinson's disease	2.45e-05	7.93e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—DDC—Parkinson's disease	2.43e-05	7.86e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TNF—Parkinson's disease	2.38e-05	7.71e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.38e-05	7.69e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.31e-05	7.49e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CYP2D6—Parkinson's disease	2.29e-05	7.43e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GSTA4—Parkinson's disease	2.29e-05	7.42e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.26e-05	7.33e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CTGF—Parkinson's disease	2.25e-05	7.29e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IGF2—Parkinson's disease	2.2e-05	7.13e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—DBH—Parkinson's disease	2.18e-05	7.06e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.18e-05	7.06e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GBA—Parkinson's disease	2.18e-05	7.06e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IGF1R—Parkinson's disease	2.13e-05	6.9e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—EDN1—Parkinson's disease	2.11e-05	6.82e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CYP2E1—Parkinson's disease	2.1e-05	6.79e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CASP3—Parkinson's disease	2.1e-05	6.78e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.08e-05	6.74e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL6—Parkinson's disease	2.08e-05	6.74e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—NQO1—Parkinson's disease	2.07e-05	6.72e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	2.06e-05	6.68e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MAOB—Parkinson's disease	2.06e-05	6.67e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—TH—Parkinson's disease	2.04e-05	6.62e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MAOB—Parkinson's disease	2.04e-05	6.62e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CYCS—Parkinson's disease	1.96e-05	6.36e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.95e-05	6.3e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NGF—Parkinson's disease	1.93e-05	6.26e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MAPK8—Parkinson's disease	1.93e-05	6.24e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—IL6—Parkinson's disease	1.92e-05	6.22e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL6—Parkinson's disease	1.9e-05	6.16e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP2D6—Parkinson's disease	1.86e-05	6.01e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HTR2A—Parkinson's disease	1.84e-05	5.96e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CTGF—Parkinson's disease	1.82e-05	5.9e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—IL6—Parkinson's disease	1.76e-05	5.69e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—COMT—Parkinson's disease	1.74e-05	5.63e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GSTP1—Parkinson's disease	1.73e-05	5.6e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—MAOA—Parkinson's disease	1.73e-05	5.59e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—APOE—Parkinson's disease	1.71e-05	5.54e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—HMOX1—Parkinson's disease	1.71e-05	5.52e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP2E1—Parkinson's disease	1.7e-05	5.5e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—IL6—Parkinson's disease	1.7e-05	5.5e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL1B—Parkinson's disease	1.69e-05	5.47e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NQO1—Parkinson's disease	1.68e-05	5.43e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MTHFR—Parkinson's disease	1.68e-05	5.43e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—TH—Parkinson's disease	1.65e-05	5.36e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ABCB1—Parkinson's disease	1.64e-05	5.3e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—DDC—Parkinson's disease	1.6e-05	5.18e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GSTM1—Parkinson's disease	1.59e-05	5.15e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYCS—Parkinson's disease	1.59e-05	5.14e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—APOE—Parkinson's disease	1.56e-05	5.06e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—MAPK8—Parkinson's disease	1.55e-05	5.01e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GPX1—Parkinson's disease	1.52e-05	4.93e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	1.52e-05	4.92e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.51e-05	4.9e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.5e-05	4.87e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CTGF—Parkinson's disease	1.49e-05	4.83e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—INS—Parkinson's disease	1.46e-05	4.74e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—COMT—Parkinson's disease	1.41e-05	4.55e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—MTHFR—Parkinson's disease	1.41e-05	4.55e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.4e-05	4.54e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GSTP1—Parkinson's disease	1.4e-05	4.53e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—MAOA—Parkinson's disease	1.4e-05	4.52e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	1.39e-05	4.5e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.39e-05	4.49e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—HMOX1—Parkinson's disease	1.38e-05	4.47e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NQO1—Parkinson's disease	1.37e-05	4.45e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—TH—Parkinson's disease	1.37e-05	4.42e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.36e-05	4.41e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—TH—Parkinson's disease	1.35e-05	4.38e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.35e-05	4.36e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—INS—Parkinson's disease	1.33e-05	4.32e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ABCB1—Parkinson's disease	1.32e-05	4.29e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.31e-05	4.25e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—APOE—Parkinson's disease	1.31e-05	4.24e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYCS—Parkinson's disease	1.3e-05	4.21e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GSTM1—Parkinson's disease	1.29e-05	4.16e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GPX1—Parkinson's disease	1.23e-05	3.99e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL6—Parkinson's disease	1.23e-05	3.98e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—COMT—Parkinson's disease	1.16e-05	3.76e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.16e-05	3.74e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.15e-05	3.73e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—COMT—Parkinson's disease	1.15e-05	3.73e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GSTP1—Parkinson's disease	1.15e-05	3.71e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MAOA—Parkinson's disease	1.14e-05	3.7e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.14e-05	3.69e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—MTHFR—Parkinson's disease	1.14e-05	3.68e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—HMOX1—Parkinson's disease	1.13e-05	3.66e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—INS—Parkinson's disease	1.12e-05	3.62e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.09e-05	3.54e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CASP3—Parkinson's disease	1.09e-05	3.53e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ABCB1—Parkinson's disease	1.08e-05	3.51e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.06e-05	3.44e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—APOE—Parkinson's disease	1.06e-05	3.43e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GSTM1—Parkinson's disease	1.05e-05	3.41e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.02e-05	3.29e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GPX1—Parkinson's disease	1.01e-05	3.26e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1e-05	3.24e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MAPK8—Parkinson's disease	1e-05	3.24e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL6—Parkinson's disease	9.89e-06	3.2e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CTGF—Parkinson's disease	9.83e-06	3.18e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MTHFR—Parkinson's disease	9.39e-06	3.04e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MTHFR—Parkinson's disease	9.3e-06	3.01e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	9.16e-06	2.97e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NQO1—Parkinson's disease	9.06e-06	2.93e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—INS—Parkinson's disease	9.04e-06	2.93e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—TH—Parkinson's disease	8.93e-06	2.89e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APOE—Parkinson's disease	8.74e-06	2.83e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APOE—Parkinson's disease	8.66e-06	2.8e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYCS—Parkinson's disease	8.57e-06	2.78e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—COMT—Parkinson's disease	7.59e-06	2.46e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTP1—Parkinson's disease	7.56e-06	2.45e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MAOA—Parkinson's disease	7.54e-06	2.44e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—INS—Parkinson's disease	7.46e-06	2.42e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HMOX1—Parkinson's disease	7.45e-06	2.41e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—INS—Parkinson's disease	7.4e-06	2.4e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ABCB1—Parkinson's disease	7.15e-06	2.32e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTM1—Parkinson's disease	6.94e-06	2.25e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GPX1—Parkinson's disease	6.65e-06	2.15e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6—Parkinson's disease	6.39e-06	2.07e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MTHFR—Parkinson's disease	6.14e-06	1.99e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6—Parkinson's disease	5.83e-06	1.89e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOE—Parkinson's disease	5.71e-06	1.85e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—INS—Parkinson's disease	4.88e-06	1.58e-05	CbGpPWpGaD
